QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:ARWR

Arrowhead Pharmaceuticals Insider Trades

$71.67
+5.84 (+8.87%)
(As of 12/7/2021 04:00 PM ET)
Add
Compare
Today's Range
$67.34
$72.82
50-Day Range
$58.09
$82.51
52-Week Range
$57.92
$93.66
Volume
796,620 shs
Average Volume
740,168 shs
Market Capitalization
$7.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.29

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.50%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
11

Amount Of
Insider Selling
(Last 12 Months)
$27.75 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ARWR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Arrowhead Pharmaceuticals (NASDAQ ARWR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Martin Javier SanInsiderSell19,500$69.31$1,351,545.00  
10/22/2021Christopher Richard AnzaloneCEOSell50,000$65.63$3,281,500.00  
10/20/2021Christopher Richard AnzaloneCEOSell15,000$66.23$993,450.00  
9/13/2021Adeoye Y OlukotunDirectorSell5,000$63.76$318,800.00  
6/24/2021Backer Marianne DeDirectorSell5,000$89.85$449,250.00  
6/22/2021Douglas B. GivenDirectorSell4,500$89.21$401,445.00  
6/22/2021James HassardInsiderSell3,625$89.22$323,422.50  
2/8/2021Patrick O'brienGeneral CounselSell90,000$88.46$7,961,400.00383,375  
1/15/2021Douglas B. GivenDirectorSell3,000$83.28$249,840.00  
1/14/2021James C HamiltonSVPSell10,000$81.29$812,900.00130,064  
1/12/2021Kenneth Allen MyszkowskiCFOSell13,038$81.02$1,056,338.76445,446  
1/7/2021James HassardInsiderSell15,625$75.00$1,171,875.00109,375  
1/6/2021Kenneth Allen MyszkowskiCFOSell30,625$72.44$2,218,475.00486,568  
1/6/2021Patrick O'brienGeneral CounselSell25,000$72.41$1,810,250.00317,233  
1/5/2021James C HamiltonSVPSell19,375$72.53$1,405,268.75171,200  
1/4/2021Douglas B GivenDirectorSell4,000$76.08$304,320.00
12/17/2020Douglas B. GivenDirectorSell9,575$79.32$759,489.00  
12/10/2020William D WaddillDirectorSell3,000$71.26$213,780.0026,800  
12/9/2020Christopher Richard AnzaloneCEOSell38,676$69.06$2,670,964.562,521,561  
11/19/2020Martin Javier SanInsiderSell19,500$69.39$1,353,105.00130,500  
10/23/2020Christopher Richard AnzaloneCEOSell100,000$58.21$5,821,000.00  
10/20/2020Kenneth Allen MyszkowskiCFOSell29,166$54.04$1,576,130.64456,834  
10/9/2020Mauro FerrariDirectorSell10,000$48.00$480,000.0030,971  
8/13/2020Christopher Richard AnzaloneCEOSell50,000$41.35$2,067,500.002,655,237  
6/25/2020Christopher Richard AnzaloneCEOSell100,000$38.81$3,881,000.002,605,260  
6/15/2020Backer Marianne DeDirectorBuy500$31.33$15,665.0013,000  
5/12/2020Michael S PerryDirectorSell36,000$35.83$1,289,880.0014,100  
4/27/2020Bruce D GivenCOOSell300$40.00$12,000.00851,934  
4/20/2020Bruce D GivenCOOSell23,515$40.00$940,600.00862,793  
4/14/2020Douglas B GivenDirectorSell25,000$36.89$922,250.00155,925  
3/16/2020Backer Marianne DeDirectorBuy500$23.94$11,970.0013,000  
3/11/2020Backer Marianne DeDirectorBuy500$28.60$14,300.0013,000  
2/27/2020Backer Marianne DeDirectorBuy500$35.07$17,535.0013,000  
1/21/2020Kenneth Allen MyszkowskiCFOSell40,313$49.44$1,993,074.72424,536  
1/13/2020Backer Marianne DeDirectorBuy500$54.95$27,475.0013,000  
1/6/2020Bruce D GivenCOOSell35,613$60.13$2,141,409.69882,759  
1/6/2020Kenneth Allen MyszkowskiCFOSell20,000$60.11$1,202,200.00403,592  
1/6/2020Patrick O'brienGeneral CounselSell14,625$60.12$879,255.00267,406  
12/12/2019Christopher Richard AnzaloneCEOSell100,000$67.50$6,750,000.002,048,684  
12/2/2019Christopher Richard AnzaloneCEOSell37,967$69.15$2,625,418.052,116,160  
11/1/2019Kenneth Allen MyszkowskiCFOSell37,884$40.85$1,547,561.40351,420  
10/10/2019Christopher Richard AnzaloneCEOSell56,325$31.83$1,792,824.752,178,228  
9/24/2019Christopher Richard AnzaloneCEOSell66,645$28.20$1,879,389.002,146,153  
9/20/2019Christopher Richard AnzaloneCEOSell4,250$29.00$123,250.002,146,153  
9/11/2019Michael S PerryDirectorSell85,000$30.00$2,550,000.00121,000  
9/9/2019Michael S PerryDirectorSell100,000$28.90$2,890,000.00121,000  
6/26/2019Mauro FerrariDirectorSell17,756$27.61$490,243.161,900  
5/28/2019Patrick O'brienGeneral CounselSell30,000$24.88$746,400.00203,000  
5/21/2019Kenneth Allen MyszkowskiCFOSell27,071$22.00$595,562.00278,536  
4/3/2019Christopher Richard AnzaloneCEOSell50,000$19.30$965,000.00  
3/1/2019Bruce D GivenCOOSell42,500$19.99$849,575.00687,106  
2/26/2019Douglas B GivenDirectorSell65,000$19.25$1,251,250.00175,130  
2/25/2019Bruce D GivenCOOSell42,500$18.98$806,650.00687,106  
2/22/2019Douglas B GivenDirectorSell3,000$18.05$54,150.00175,130  
2/19/2019Bruce D GivenCOOSell68,750$17.86$1,227,875.00644,606  
2/19/2019Kenneth Allen MyszkowskiCFOSell8,000$18.00$144,000.00313,607  
2/15/2019Bruce D GivenCOOSell26,250$17.67$463,837.50644,606  
2/12/2019Bruce D GivenCOOSell242,834$16.04$3,895,057.36859,523  
2/8/2019Bruce D GivenCOOSell46,167$15.34$708,201.78859,523  
2/5/2019Bruce D GivenCOOSell22,500$14.48$325,800.00847,856  
2/1/2019Bruce D GivenCOOSell28,500$13.85$394,725.00870,356  
1/23/2019Bruce D GivenCOOSell169,500$13.54$2,295,030.00916,356  
1/22/2019Douglas B GivenDirectorSell3,000$13.58$40,740.00178,130  
1/18/2019Patrick O'brienGeneral CounselSell72,000$14.43$1,038,960.00233,000  
1/17/2019Kenneth Allen MyszkowskiCFOSell81,875$14.55$1,191,281.25305,607  
1/14/2019Bruce D GivenCOOSell42,666$14.40$614,390.401,110,022  
1/14/2019Zhen LiVPSell40,500$14.34$580,770.00201,700  
1/11/2019William D WaddillDirectorSell8,500$14.77$125,545.0046,500  
1/2/2019Bruce D GivenCOOSell20,000$11.98$239,600.001,118,356  
1/2/2019Kenneth Allen MyszkowskiCFOSell8,333$11.98$99,829.34395,815  
12/27/2018Douglas B. GivenDirectorSell3,000$12.00$36,000.00  
12/19/2018Christopher Richard AnzaloneCEOSell90,000$13.92$1,252,800.00  
12/12/2018Christopher Richard AnzaloneCEOSell90,000$14.07$1,266,300.00  
11/23/2018Douglas B. GivenDirectorSell3,000$12.74$38,220.00  
11/9/2018Christopher Richard AnzaloneCEOSell81,500$14.39$1,172,785.001,727,755  
10/19/2018Peter Brian LeoneVPSell131,137$13.49$1,769,038.13160,000  
9/6/2018Kenneth Allen MyszkowskiCFOSell45,000$19.34$870,300.00335,815  
9/4/2018Christopher Richard AnzaloneCEOSell164,834$14.45$2,381,851.301,868,789  
8/31/2018Christopher Richard AnzaloneCEOSell100,000$14.45$1,445,000.001,868,789  
6/19/2018Kenneth Allen MyszkowskiCFOSell20,000$14.01$280,200.00330,815  
5/31/2018Kenneth Allen MyszkowskiCFOSell14,000$11.00$154,000.00312,215  
4/24/2018Douglas B. GivenDirectorSell25,000$6.63$165,750.00  
3/27/2018Kenneth Allen MyszkowskiCFOSell20,000$8.00$160,000.00330,815  
3/15/2018Christopher Richard AnzaloneCEOSell300,000$7.43$2,229,000.002,194,789  
3/13/2018Christopher Richard AnzaloneCEOSell100,000$7.43$743,000.002,194,789  
3/5/2018Bruce D GivenCOOSell20,000$6.73$134,600.00908,356  
1/1/2018Bruce D GivenCOOSell20,000$3.69$73,800.00948,356  
10/14/2016Douglas B. GivenDirectorSell12,000$6.72$80,640.00  
8/23/2016Kenneth Allen MyszkowskiCFOSell6,900$8.00$55,200.00128,789  
8/22/2016Kenneth Allen MyszkowskiCFOSell13,100$8.00$104,800.00128,789  
12/30/2015Kenneth Allen MyszkowskiCFOSell23,347$6.13$143,117.11135,000  
10/28/2015Mauro FerrariDirectorBuy400$7.62$3,048.00  
10/9/2015Mauro FerrariDirectorBuy1,900$6.19$11,761.00  
1/5/2015David L LewisInsiderSell15,000$8.01$120,150.00  
10/15/2014Christopher Richard AnzaloneCEOBuy16,000$6.32$101,120.00  
10/1/2014Charles MckenneyDirectorSell2,500$14.70$36,750.00  
9/30/2014David L LewisInsiderSell15,000$15.02$225,300.00  
9/26/2014Douglas B GivenDirectorSell2,000$15.24$30,480.00  
6/9/2014Charles MckenneyDirectorSell22,000$14.32$315,040.00  
2/12/2014Kenneth Allen MyszkowskiCFOSell16,000$18.77$300,320.00  
2/7/2014Edward W FrykmanDirectorSell3,148$15.98$50,305.04  
(Data available from 1/1/2013 forward)












Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Trade Frequently Asked Questions

Who is on Arrowhead Pharmaceuticals's Insider Roster?

The list of insiders at Arrowhead Pharmaceuticals includes Adeoye Y Olukotun, Backer Marianne De, Bruce D Given, Christopher Richard Anzalone, Douglas B Given, James C Hamilton, James Hassard, Kenneth Allen Myszkowski, Martin Javier San, Mauro Ferrari, Michael S Perry, Patrick O'brien, William D Waddill, and Zhen Li.Learn more on ARWR's insiders

What percentage of Arrowhead Pharmaceuticals stock is owned by insiders?

3.50% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings

Which Arrowhead Pharmaceuticals insiders have been buying company stock?

The following insider purchased Arrowhead Pharmaceuticals stock in the last 24 months: Backer Marianne De ($86,945.00).

How much insider buying is happening at Arrowhead Pharmaceuticals?

Insiders have purchased a total of 2,500 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $86,945.00 bought.

Which Arrowhead Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Arrowhead Pharmaceuticals stock in the last 24 months: Adeoye Y Olukotun ($318,800.00), Backer Marianne De ($449,250.00), Bruce D Given ($3,094,009.69), Christopher Richard Anzalone ($25,465,414.56), Douglas B Given ($1,226,570.00), James C Hamilton ($2,218,168.75), James Hassard ($1,495,297.50), Kenneth Allen Myszkowski ($8,046,219.12), Martin Javier San ($2,704,650.00), Mauro Ferrari ($480,000.00), Michael S Perry ($1,289,880.00), Patrick O'brien ($10,650,905.00), and William D Waddill ($213,780.00).

How much insider selling is happening at Arrowhead Pharmaceuticals?

Insiders have sold a total of 968,571 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $59,063,718.62 sold.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]arketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.